Herstellung von 1,1-Dihaloalkanen
Ana Martı́nez(Consejo Superior de Investigaciones Científicas), L. R. Subramanian, José Osío Barcina(Universidad Complutense de Madrid), Roberto Martínez Álvarez(Universidad Complutense de Madrid), M. Hanack(Universidad Complutense de Madrid), J. Bueno Calderón(Universidad Complutense de Madrid), Amelia Garcı́a Fraile
Cited by 24
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
|Brain Behavior and Immunity|2018|293